The development of NK cells from hematopoietic stem cells is thought to be dependent on IL-15. In this study, we demonstrate that stimulation of human cord blood CD34
N atural killer cells are critical for host immunity because they rapidly mediate cellular cytotoxicity against pathogen-infected or malignantly transformed cells and produce a wide variety of cytokines and chemokines that influence other components of the immune system. Unlike other lymphocytic lineages, however, the continuous staging scheme of human NK cell development in vivo has yet to be elucidated (1) . One reason for this may be the difficulty in closely correlating our knowledge of mouse NK cell biology with human NK cell biology (2) , because mouse NK cells do not express a homolog of CD56, which is the marker most representative of human NK cells; instead, the most widely used markers of NK cells in various mouse strains are NK1.1 and DX5, mouse-specific Ags. Among the molecules involved in NK cell development, IL-15 has a particularly important role. For example, IL-15-deficient mice lack NK1.1 ϩ cells (3), indicating that IL-15 is essential for NK cell development in mice. The requirement of IL-15 for mouse NK cell development has also been demonstrated by other studies (4, 5) . In humans, IL-15 is considered to be required for in vitro NK cell development and virtually most current protocols for human NK cell differentiation culture depend on IL-15. IL-15-independent NK cell differentiation has been reported in which human cord blood (CB) 9 cells are cocultured with murine stromal cell lines (6) . Signaling, however, substituting IL-15 signaling that is responsible for the NK cell differentiation in this culture system was not described.
NK cells are thought to be derived from hematopoietic stem cells through a T/NK precursor stage. The Notch signaling pathway influences cell fate decisions in numerous cellular systems, including various hematopoietic and immune cells (7) (8) (9) . To date, four Notch receptors (Notch1-Notch4) and at least four Notch ligands (Delta1, Delta4, Jagged1, and Jagged2) have been identified in mammals. Signaling through Notch1 is crucial in the early stages of T cell development (10 -12) . In culture, ligand-induced Notch signaling drives human CB CD34 ϩ cells to differentiate into T/NK cell precursors (13) . Furthermore, Notch signaling drives the T/NK precursors toward differentiation into T and NK cells, although the results for the NK cells are controversial. For example, inhibition of Notch signaling suppresses T cell development and stimulates NK cell development (14 -16) , whereas activation of Notch signaling contributes to the efficient development of NK cells in mice (17, 18) and humans (19) . It is not concluded, however, whether Notch signaling is involved in the function of NK cells or whether IL-15 is necessary for NK cell development in culture.
In this report, to gain further insight into the physiologic significance of Notch signaling in NK cell development, we examined whether IL-15 is dispensable for the generation of functional NK cells and whether Notch signaling has a role in the later stages of NK cell development. Our results indicated that Notch signaling, but not IL-15 stimulation, was essential for inducing CD34 ϩ cells to give rise to CD7 ϩ and cytoplasmic (cy) CD3 ϩ cells that express CD56 in stroma-free culture. Surprisingly, cells cultured with Delta4-coated plates, but lacking IL-15 in the medium, were functional NK cells with cytotoxic activity. IL-15, along with Delta4, further augmented NK cell activity and phenotypic maturation. The addition of IL-15 without exogenous Notch ligand, however, did not allow CD34 ϩ cells to take a NK cell developmental pathway resembling physiologic NK cell precursors. Notch signaling might have a significant role in the development of NK cells in vivo.
Materials and Methods

Reagents and Abs
Recombinant human Delta4-Fc chimeric protein was generated as described previously (20) . Recombinant human IL-7 and IL-15 were purchased from R&D Systems. Human stem cell factor and human Fms-like kinase 3 ligand (FL) were a gift from Amgen. Human IL-6/IL-6 receptor fusion protein (FP6) and human thrombopoietin were provided by Kirin Pharma. Anti-IL-15 Ab (MAB2471) and isotype control mouse IgG1 were purchased from R&D Systems. Anti-CD3 (UCHT1), CD8 (SK1), CD14 (M5E2), CD44 (G44-26), CD45 (HI30), CD45RA (HI100), CD56 (B159), CD94 (HP-3D9), CD161 (DX12), NKG2D (1D11), CCR7 (3D12), granzyme B (GB11), and IFN-␥ (25723.1) Abs were purchased from BD Biosciences. Anti-CD2 (T11), CD4 (13B8.2), CD7 (8H8.1), CD11a (25.3), CD11b (Bear1), CD25 (B1.49.9), CD27 (1A4CD27), CD33 (D3HL60.251), CD57 (NC1), CD62L (DREG56), CD117 (YB5.B8), CD122 (CF1), CD158a (EB6), and CD158b (GL183) Abs were purchased from Beckman Coulter. Anti-CD34 and CD133 Abs were purchased form Miltenyi Biotec. RIK-2, anti-TRAIL mAb, was prepared as described previously (21) .
Isolation of CD34
ϩ and CD133 ϩ cells
Human CB samples were collected from normal full-term deliveries. The parents of all donors provided written informed consent to participate in the study. The procedures were approved by the institutional review board. Mononuclear cells were separated from blood samples by density gradient centrifugation (Lymphoprep; AXIS-SHIELD PoC). CD34-and CD133-enriched cells were separated from mononuclear cells using a MACS Direct CD34 Progenitor Cell Isolation Kit and MACS CD133 MicroBead Kit (Miltenyi Biotec), respectively, according to the manufacturer's protocol. The purity of the CD34 ϩ and CD133 ϩ cells was 97.3 Ϯ 2.3% (n ϭ 15) and 95.4 Ϯ 3.2% (n ϭ 4), respectively. Residual CD3 ϩ and CD56 ϩ cells were 0.73 Ϯ 0.42% and 0.41 Ϯ 0.32%, respectively, in either purification strategy.
Cell culture
Nontissue culture-type 24-well plates were precoated by applying 10 g/ml Delta4-Fc or control Fc fragments of human Ig G (Fc) (Athens Research & Technology) to the plates at 37°C for 1 h. Cells were cultured in MEM Eagle, ␣ modification (Sigma-Aldrich) supplemented with 20% FBS (Thermo Trace) and penicillin-streptomycin at 37°C in a humidified atmosphere flushed with 5% CO 2 in air. The number of CD34 or CD133 magnetic bead-sorted cells seeded in each well was 0.25-1.2 ϫ 10 5 . Cytokines were added at concentrations of 10 ng/ml for IL-7, 100 ng/ml for stem cell factor and 100 ng/ml for FL. one-half of the culture medium was changed every 3 or 4 days. Ten nanograms of thrombopoietin per ml and 100 ng/ml FP6 were added only into the starting culture medium for effective proliferation, although they were not essential (data not shown). IL-15 was added at 5 ng/ml when indicated. Anti-IL-15 or isotype IgG was added at 10 g/ml when indicated. To inhibit Notch signaling, 10 mol/L ␥-secretase inhibitor N-[N- (3,5-difluorophenacetyl-L-alanyl) ]-S-phenylglycine tert-butyl ester (DAPT; Calbiochem) was added to the culture medium. CD161
ϩ and CD161 Ϫ cells from the culture were isolated using FACSAria (BD Biosciences) after staining with anti-CD161-PE Ab.
Phenotyping assay
Immunofluorescence staining for flow cytometry was performed according to standard procedures. To exclude dead cells from the analysis, 7-aminoactinomycin D (Beckman Coulter) was used. Cytoplasmic staining was performed as follows: after staining the cells with anti-CD56-allophycocyanin and fixing with FACS lysing solution (BD Biosciences), the cells were permeabilized using FACS permeabilizing solution (BD Biosciences) and stained with anti-CD3-PE Ab. For staining for granzyme B, the same fixing and permeabilizing procedure was performed after cell surface staining with anti-CD56-PE and anti-CD3-allophycocyanin. For staining for TRAIL, the cells were incubated with 1 g of RIK-2 for 30 min at 4°C followed by anti-mouse IgG1-PE (A85-1). Cells were analyzed by flow cytometry using FACSCalibur and CellQuest software (BD Biosciences).
Cytotoxicity assays
A 51 Cr release assay to determine cytotoxicity was performed using standard procedures. In brief, 5 ϫ 10 3 K562 or Jurkat cells were labeled with Na 2 51 CrO 3 (Amersham Biosciences) and cocultured with effector cells at various ratios in 96-well round-bottom microtiter plates in 200 l of culture medium. The cocultured cells were incubated for 4 h, and 100 l of supernatant was collected from each well and counted with a Packard COBRA gamma counter (Packard Instruments). The percentage of specific 51 Cr release was calculated as follows: [cpm experimental release Ϫ cpm spontaneous release]/(cpm maximal release Ϫ cpm spontaneous release) ϫ 100. The ratio of spontaneous release to maximal release was Ͻ20% in all experiments. In experiments to test the mode of cytotoxicity, we used concanamycin A (CMA; Sigma-Aldrich) as a selective inhibitor of the perforin-mediated cytotoxicity, and anti-TRAIL Ab RIK-2. Effectors were pretreated with 100 nmol/L CMA for 2 h before the cytotoxicity assays (22) . RIK-2 was added at a final concentration of 10 g/ml at the start of the cytotoxicity assay.
Intracellular cytokines
The cells were stimulated by PMA (25 ng/ml; Sigma-Aldrich) and ionomycin (1 g/ml; Sigma-Aldrich) in the presence of monensin (2 mol/L; Sigma-Aldrich) for 4 h. After staining the cells with anti-CD56-PE, they were fixed and permeabilized as described above and stained with anti-IFN-␥-FITC Ab. The cells were analyzed on a FACSCalibur using CellQuest software.
Anti-Notch Abs
For cell surface staining, we used biotinylated Abs and streptavidin-PE (BD Biosciences). To block Notch1, we added 10 (g/ml) MHN1-519 to the medium. Mouse IgG1 (R&D Systems) was used as the control. The anti-human Notch1 (MHN1-519, mouse IgG1), Notch2 (MHN2-25, mouse IgG2a), and Notch3 (MHN3-21, mouse IgG1) mAbs were generated by immunizing BALB/c mice with human Notch1-Fc (R&D Systems), Notch2-Fc (the Fc portion of human IgG1 was fused to the 22nd epidermal growth factor repeat of the extracellular region of human Notch2), or Notch3-Fc (R&D Systems) and screening hybridomas producing mAbs specific for Notch1-Fc, Notch2-Fc, or Notch3-Fc by ELISA. MHN1-519, MHN2-25, and MHN3-21 reacted with CHO(r) cells (23) 
Results
Human CB CD34 ϩ and CD133 ϩ cells gave rise to functional NK cells by Notch signaling in a stroma-free culture without exogenous IL-15
CD34
ϩ or CD133 ϩ cells were cultured on Delta4-Fc-coated plates. The cells became almost immunophenotypically homogeneous after culture for ϳ3 wk (Fig. 1A) . The proliferation efficiency depended on CB batches; fold increases in the cell number after the 3-wk culture were 10.3 Ϯ 7.74-fold (n ϭ 11). These cells expressed CD56 and CD161, but did not express surface CD3 or TCR␣/␤ (data not shown). CD56/CD161 double-positive cells also expressed NKG2D and CD117, but were essentially negative for CD16 and killer Ig-like receptors (CD158a and CD158b). The cells had cytotoxic activity against K562 (Fig. 1C ) and Jurkat cells (see Fig. 5Bii ), and secreted IFN-␥ (Fig. 1D ). These results indicate that the culture products meet the general criteria for functional NK cells. The products generated from CB CD34 ϩ and CD133 ϩ had the same characteristics (data not shown).
Virtually no NK cells developed in culture on control Fccoated plates; the vast majority of the cells were CD33 ϩ myeloid cells, a significant part of which expressed CD14 (Fig. 2) . The absolute cell numbers with control Fc are ϳ5-fold higher than that with Delta4-Fc, and the fold increases in the cell number after the 3-wk culture were 45.7 Ϯ 31.6-fold (n ϭ 11). To confirm that the NK cell differentiation was Notch dependent, we added a ␥-secretase inhibitor, DAPT, which strongly inhibits ligand-dependent Notch activation (24, 25) . The cells cultured on Delta4-Fc-coated plates in the presence of DAPT had the same immunophenotype as those cultured on the control Fc-coated plates and did not give rise to NK cells (Fig. 2) , indicating that the observed NK cell development was Notch activation dependent. The number of cells generated increased to the level of that in the control Fc protein-coated plates (data not shown).
We cultured CD34 ϩ cells and CD133 ϩ cells purified from G-CSF-mobilized peripheral blood cells. Both cell types gave rise to CD56 ϩ CD161 ϩ NK cells that were similar to those derived from CB CD34 ϩ or CD133 ϩ cells. Fig. 3 ), although the time courses varied to some degree from batch to batch (supplemental Fig. S2 and data not shown).
We next examined the effects of other soluble Notch ligands, human Delta1-Fc and Jagged1-Fc, on NK cell development from CB CD34 ϩ cells. Delta1-Fc had an effect similar to that of Delta4-Fc, although with lower efficiency (supplemental Fig. S1B ), and Jagged1-Fc showed no potential to induce NK cell development (data not shown). Therefore, we used Delta4-Fc as the soluble Notch ligand and CB CD34 ϩ cells as the starting material for the remaining experiments.
IL-15 is dispensable for in vitro NK cell development from CB CD34 ϩ cells in the presence of Delta4 stimulation, whereas Notch stimulation appears to be essential for physiologic NK cell development
When IL-15 was added to the culture medium on control Fccoated plates, CD56 ϩ CD161 ϩ NK cells emerged ( 11%, and 88 Ϯ 6.7% (without IL-15) at 2, 3, and 4 wk, respectively. (supplemental Fig. S2Bi ) The differences were statistically significant between the D4-Fc group and the Fc group ( p Ͻ 0.001). The adjusted absolute numbers of NK-lineage cells cultured on Delta4-Fc tended to be greater than those cultured on Fc with IL-15, although the differences were not always statistically significant (supplemental Fig. S3C ). CD56 ϩ
CD161
ϩ NK cells eventually comprised a major population after 6 wk of culture with IL-15 but without Notch stimulation (Fig. 4Ai) . No CD56 ϩ CD7 ϩ (Fig. 3 , Fc plus IL-15) or CD56 ϩ cyCD3 ϩ (Fig. 4Aii ) cells were detected during culture with IL-15 but without Delta4-Fc, whereas Delta4-Fc stimulation induced the generation of CD7 ϩ cyCD3 ϩ cells, which could represent naturally arising T/NK cell progenitors (26, 27) , at the early phase of the culture. Although CD7 low cells appeared in culture with IL-15 alone, they might represent monocytes, because a substantial amount of CD14 ϩ cells emerged regardless of the presence of IL-15 when Delta4-Fc was absent and peripheral blood monocytes express CD7 at low levels. demonstration that CD161 is expressed on the cell surface earlier than CD56 (28), the former possibility appears more likely. To explore the possibility that IL-15 is secreted by a certain population of cells during culture and contributes to NK cell development, we added anti-IL-15-neutralizing Ab to the culture. The addition of anti-IL-15-neutralizing Ab to the culture medium blocked NK cell development in the presence of IL-15 ( Fig. 3 , IL-15 plus anti-IL-15), but did not affect either the rate or efficiency of Delta4-Fc-dependent NK cell emergence (Fig.  3 , D4-Fc plus anti-IL-15, fold increase in the cell number after 3-wk culture on Delta4-coated plate with anti-IL-15 was 8.75 Ϯ 4.18-fold (n ϭ 5), which was not statistically different from those cultured on Delta4-coated plates without anti-IL-15 or with IL-15), further supporting the possibility that IL-15 is dispensable for NK cell development from human CB CD34 ϩ cells. IL-2 is also suggested to be involved in the NK cell development. To examine whether IL-2, which might be secreted by a certain population of the cells, was present in the culture, the IL-2 concentration in the supernatant was measured by ELISA. No IL-2 was detected (cutoff level, 7 pg/ml; data not shown), indicating that IL-2 was not involved in the NK cell development induced by Delta4-Fc.
To examine the NK cell developmental stages that are critically dependent on Notch signaling, we cultured CB CD34 ϩ cells on control Fc-coated plates with IL-15 for 1 or 2 wk and then transferred them onto Delta4-Fc-coated plates and cultured them further for 3 or 2 wk without IL-15, respectively (culturing for a total of 4 wk). Approximately 50% of the CD56 ϩ
ϩ population expressed CD7 ϩ at 4 wk in the 1-wk IL-15 condition (Fig. 4Bii) . In contrast, very few CD56 ϩ cells that emerged in the 2-wk IL-15 condition expressed CD7 (Fig. 4Bi) . These observations indicated that CB CD34 ϩ cells cultured with IL-15, but without Notch stimulation, for 1 wk retained the capacity to generate CD56 ϩ CD7 ϩ cells, but that they lost this capacity when cultured without Notch stimulation for 2 wk. We also examined whether the Notch stimulation at early phases of the culture irreversibly determines NK cell developmental fate. To examine the early phase of NK cell development, we cultured CB CD34 ϩ cells for 2 wk on Delta4-Fc-coated plates and sorted the product into CD161 ϩ and CD161 Ϫ cells, because CD161 is known to be expressed earlier than CD56 on the cell surface (28) . We then transferred each population onto control Fc-coated plates and cultured them for another week without IL-15. More than 80% of the population derived from the CD161 ϩ cells expressed CD7 ϩ . Interestingly, the CD161 Ϫ cells also gave rise to CD161 ϩ CD7 ϩ cells among one of the two major populations (Fig. 4C) . These observations indicate that Notch activation irreversibly drives a subset of CD34 ϩ cell progenies to the CD161 ϩ CD7 ϩ NK cell fate within 2 wk, presumably before CD161 ϩ is expressed.
IL-15, along with Delta4 stimulation, induces phenotypic maturation and functional augmentation of CB CD34
ϩ
cell-derived NK cells
We compared the immunophenotype of the CB CD34 ϩ cell-derived NK cells generated in the culture with Delta4-Fc but lacking IL-15 (D4-Fc) and in culture with Delta4-Fc and IL-15 (D4-Fc plus IL-15). IL-15 does not affect the absolute cell number; fold increases in the cell number after the 3-wk culture were 10.6 Ϯ 6.16-fold and 10.2 Ϯ 6.71-fold with and without IL-15 in the D4-Fc-coated plate condition (n ϭ 8). The cells grew slightly faster with D4-Fc plus IL-15 than with D4-Fc alone, but there were no significant differences in the frequency of CD56 ϩ CD161 ϩ population in both conditions after 3 wk (cf Fig. 3 and supplemental 5 ). The expression levels of CD7 and NKG2D were similar. CD94 was expressed at a higher level in the D4-Fc plus IL-15 condition. CD16 and CD158 were not expressed in the D4-Fc condition, but were expressed at low levels in the D4-Fc plus IL-15 condition. The expression levels of adhesion molecules, i.e., CD11a, CD11b, and CD62L, were higher in the D4-Fc condition (Fig. 5A) . The other markers shown in Fig. 1 (CD2, CD7, CD25 , CD27, CD44, CD45RA, CD57, CD117, CD122, and CCR7; data not shown), as well as IFN-␥ (Fig. 5D) , were expressed at similar levels under both conditions. There was a remarkable difference in the expression level of CD56, which was markedly higher in the D4-Fc plus IL-15 condition.
Cytotoxic activity against K562 cells was significantly higher in NK cells generated in the D4-Fc plus IL-15 condition than that in the D4-Fc condition. CMA, an inhibitor of perforin-mediated cytotoxicity, had a stronger suppressive effect on the cytotoxic activities of NK cells generated in the D4-Fc plus IL-15 condition (Fig. 5Bi) . Interestingly, granzyme B, which enhances the perforin-mediated cytotoxicity and whose expression was not detected in the D4-Fc condition, was up-regulated in the D4-Fc plus IL-15 condition (Fig. 5Ci) . This might explain the stronger suppression of NK cell cytotoxic activity by CMA when generated in the D4-Fc plus IL-15 condition compared with the D4-Fc condition. In contrast, there was no significant difference in the killing activities against Jurkat cells of the NK cells generated under either condition (Fig. 5Bii) , and CMA did not affect the cytotoxic activities against Jurkat cells, irrespective of the culture conditions (data not shown). This finding suggests that perforin or granzyme B does not have a major role in killing Jurkat cells. We evaluated whether TRAIL had a role by adding anti-TRAIL-blocking Ab RIK2 to the medium. RIK2 partially but clearly suppressed the cytotoxic activities against Jurkat cells generated in both conditions without significant differences (Fig. 5Bii) , although TRAIL expression was slightly higher in the NK cells generated in the D4-Fc plus IL-15 condition (Fig. 5Cii) . From these observations, we concluded that IL-15 does not influence the killing activity through TRAIL but does enhance the killing activity through perforin/granzyme B. The cytotoxic activity of immature NK cells is TRAIL dependent, while that of mature NK cells is mainly dependent on perforin (29) . Therefore, IL-15 might contribute to the maturation of NK cells and confer on them the capacity to exact perforin/granzyme B-medicated cytotoxicity.
Inhibitory effect of anti-Notch1 Ab on Delta4-dependent NK cell development
We prepared mAbs specific for the extracellular domain of Notch1, Notch2, and Notch3 (supplemental Fig. S4A ). The expression patterns of Notch1, Notch2, and Notch3 in fresh CB mononuclear cells, CD34
ϩ cells, and products during the culture of CD34 ϩ cells are shown in supplemental Fig. S3 , A and B. Notch1 was expressed at higher levels on NK and T cells than on B cells and monocytes. Notch2 was expressed at higher levels on monocytes than on lymphocytes. Notch3 expression was virtually negative on all types of lymphocytes and positive on monocytes. Notch1 and Notch2, but not Notch3, were expressed on CD34 ϩ cells. The CD34 ϩ cell-derived CD56 ϩ NK cells also expressed Notch1 and Notch2, but not Notch3. All three Notch receptors were expressed on cells grown on the control Fc-coated plates (supplemental Fig. S3B ).
Because CD34 ϩ cells expressed Notch1 and Notch2, but not Notch3 (supplemental Fig. S3B) , and the established anti-Notch1 Ab, but not anti-Notch2 Ab, blocked binding of the cognate soluble Notch receptor to the ligands (supplemental Fig. S4B ), we cultured CB CD34 ϩ cells on Delta4-Fc-coated plates in antiNotch1 Ab-containing medium. Remarkably, the immunophenotype of the cells grown under the presence of anti-Notch1 Ab was almost the same as that of cells grown on control Fc-coated plates, indicating that the effect of Delta4 was completely blocked and NK cell development was shut down by the anti-Notch1 Ab (Fig. 6A) . Anti-Notch2 Ab did not have such an effect, consistent with the fact that it did not block ligand binding to the cognate receptors (data not shown). CB CD34 ϩ cells cultured with IL-15 on Fccoated plates in the presence of the anti-Notch1 Ab gave rise to NK cells in a manner indistinguishable from that of cells grown without the Ab (Fig. 6B) . These results suggest that Notch1 might be a physiologic Notch receptor that mediates Delta4 signaling for NK cell development from CB CD34 ϩ cells and further support the notion that Notch signaling has a role distinct from that of IL-15.
Discussion
In the present study, we demonstrated that functional NK cells developed from CB CD34 ϩ cells when stimulated with the Notch ligand Delta4. Previous reports indicated that NK cells can be derived from in vitro culture of human CD34 ϩ cells prepared from fetal liver, bone marrow, or CB with either IL-2 or IL-15 (30 -33) , which signal through the shared IL-2/IL-15 receptor ␤-chain and the common ␥-chain. IL-15 has been considered to have a more physiologic role than IL-2 in NK development (30) . Notably, IL-15-independent NK cell differentiation has recently been published (6) . This culture system, however, has been reported to be stromal cell dependent while the potential molecules and signaling pathways are unknown and, thus, the conclusion whether IL-15 is indispensable is yet to be determined. Notch signaling has been examined in the context of NK cell development as well and appears to affect the very early phase of progenitor development (17) (18) (19) . In studies of human NK cell development, however, culture systems containing IL-15 and/or a coculture system with the fetal thymus organ or stromal cells are used exclusively. A novel and unexpected finding in the present study was the fact that stimulation of CB CD34 ϩ cells with a soluble Notch ligand, Delta4-Fc, coated onto the plate in the presence of stem cell factor, FL, and IL-7 was sufficient to induce the development of functional NK cells.
Our data do not officially exclude the possibility that endogenous IL-15 is involved in NK cell development in a manner, e.g., that cell-autonomously produced IL-15 activated the signaling by binding to the receptor intracellularly. Given the fact, however, that the exogenous addition of IL-15 resulted in the qualitative rather than quantitative difference in the NK cells developed in the presence of Delta4-Fc, in addition to inefficient blockade by anti-IL-15-neutralizing Ab, IL-15 is likely to be dispensable for human NK cell development in the presence of Delta4-Fc.
The finding that IL-15 is not necessary for human NK cell development in culture contrasts with the absolute necessity of IL-15 signaling for NK development in some mouse phenotypes; mice lacking a gene for IL-15 (3) (34, 35), IL-15 receptor ␣-chain (36), common ␤-chain (37), or common ␥-chain (38, 39) lack NK cells. This might be due to differences between the in vitro culture conditions and the in vivo environment in which NK cells develop. Another explanation might be a difference between mice and humans, as in the case of IL-7 requirement for T cell development; IL-7 is required for the V-D-J rearrangement of the TCR ␤-chain gene in humans, whereas it is dispensable in mouse T cell development (40) .
Previous studies reported that the effect of Notch signaling in the presence of IL-15 on NK cell development is confined to the very early stages of development. In the present study, we demonstrated that Notch signaling confers CD7 expression competence on cells cultured with or without IL-15 for 1 wk or less, but not for 2 wk, unless also stimulated by Notch. This finding is similar to that in a previous report demonstrating that Notch signaling confers cyCD3 expression competence only on prethymic but not thymic NK cell progenitors or peripheral blood cyCD3 Ϫ NK cells (19) . We confirmed the Notch signal dependency of cyCD3 expression during NK cell development. Coexpression of CD7 and CD45RA on CD34 ϩ cells might be associated with a restriction toward NK cell development (26, 33) . Our data strongly suggest that the vast majority, if not all, of the NK cells derived from CD34 ϩ cells without Notch signaling were generated through CD7 Ϫ cells. Therefore, although it is yet to be elucidated whether all of the NK cell progenitors are CD7 ϩ (41), NK cells established in vitro without Notch stimulation might not develop from a physiologic NK progenitor or might skip the physiologic NK/T progenitor stage. Furthermore, our data suggest that the effect of Notch stimulation on CD7 expression is imprinted on cells only if it is administered at the initial stage of the CD34 ϩ cell culture. We, however, failed to prospectively identify the subpopulations in the CD34 ϩ cells that are targets of Delta4 to develop NK-lineage cells. Delta4 stimulation induced NK cell development from both the most immature CD34
ϩ CD38 Ϫ and more mature CD34 ϩ CD38
ϩ progenitor populations and both CD34 ϩ CD45RA ϩ lymphoid progenitors and CD34 ϩ CD45RA Ϫ populations (data not shown).
The findings of the present study extend our understanding to more mature stages of NK cell differentiation: the presence of Notch signaling induces generation of functional NK cells in culture conditions that do not generate CD56 ϩ cells without Notch stimulation per se. The precise stages of NK cell development during which Notch signaling determines the progression toward functional NK cells is not known.
In our experiments, even cells cultured with a Notch ligand alone had cytotoxic activity. The level of this activity, however, was weaker than that in NK cells generated by Notch stimulation with IL-15. Indeed, the perforin-mediated cytotoxicity of NK cells generated in the absence of IL-15 was significantly weaker, despite the fact that this is the major pathway of mature NK cells to kill target cells (42) . In contrast, the TRAIL-mediated cytotoxicity was almost the same regardless of presence or absence of IL-15. This finding, along with the change in the expression level of CD56, might indicate that IL-15 induces the maturation of CD56 low CD161
ϩ immature NK cells generated by Notch stimulation without IL-15. Another difference between the cells cultured with or without IL-15 was the down-regulation of adhesion molecules (CD11a, CD11b, CD62L) on the cell surface. These molecules might be important for homing of the NK cells to the sites at which they function.
To our surprise, cytotoxic activities were not detected in the cell populations generated in the control Fc plus IL-15 condition at either 3 or 6 wk ( Fig. 5B and data not shown), although these results might be affected by the facts that the frequency of CD56 ϩ CD161 ϩ cells was very low at 3 wk and that culture for 6 wk might be too long to evaluate cytotoxic activities while the frequency of CD56 ϩ CD161 ϩ cells was much greater. In any case, when clinical application of progenitor-derived NK cells is considered, a Delta4-Fc-coating system would give a significant advantage.
In conclusion, Notch stimulation by Delta4 (or Delta1) was required for initial NK cell differentiation and the development of CD161 ϩ CD56 low immature NK cells. Among Notch receptors, Notch1 might be essential for physiologic NK cell development, although the involvement of other Notch receptors is yet to be elucidated. IL-15 was not essential for differentiation, but was necessary for maturation. IL-15 might have an indispensable role only in the later part of the NK development. This knowledge might be useful for future approaches toward the ex vivo generation and manipulation of NK cells and their therapeutic application.
